The purpose of this study is to investigate metastatic pancreatic cancer. It evaluates the use of endoscopic ultrasonography-guided radioactive iodine 125 seeds combined with chemotherapy.
This study evaluates the safety and effectiveness of combining local radiation therapy with chemotherapy. It looks at how this combination might affect overall survival and examines potential adverse events.
- Who can participate: Participants aged 18 to 80 years with Stage IV pancreatic ductal adenocarcinoma and distant metastases are eligible. They must have no prior treatment history and meet specific health criteria.
- Study details: Participants will receive an implantation of radioactive seeds followed by chemotherapy. A placebo is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand